From: Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
Characteristic | Patients (n) | Patients (%) | Median survival (months) | 5-Year survival (%) | P |
---|---|---|---|---|---|
Age | |||||
<20 years | 17 | 9 | 190 | 47 | 0.064 |
20–59 years | 85 | 44 | 235 | 63 | |
≥60 years | 91 | 47 | 111 | 51 | |
Gender | |||||
Male | 81 | 42 | 235 | 60 | 0.087 |
Female | 112 | 58 | 180 | 53 | |
Nationality | |||||
Norwegian | 131 | 68 | 228 | 62 | 0.005 |
Russian | 62 | 32 | 81 | 44 | |
Histology | |||||
Pleomorphic sarcoma | 57 | 30 | 52 | 45 | 0.031 |
Leiomyosarcoma | 47 | 24 | 89 | 64 | |
Liposarcoma | 32 | 17 | NR | 71 | |
MF/MFT | 16 | 8 | 123 | 56 | |
Angiosarcoma | 8 | 4 | 10 | 38 | |
Rhabdomyosarcoma | 9 | 5 | NR | 67 | |
MPNST | 9 | 5 | NR | 56 | |
Synovial sarcoma | 12 | 6 | 31 | 30 | |
Other STS | 3 | 2 | NR | - | |
Tumor localization | |||||
Extremities | 78 | 40 | 201 | 56 | 0.922 |
Trunk | 37 | 19 | 214 | 53 | |
Retroperitoneum | 27 | 14 | 135 | 51 | |
Head/Neck | 13 | 7 | 191 | 58 | |
Visceral | 38 | 20 | 202 | 62 | |
Tumor size | |||||
<5 cm | 57 | 30 | 257 | 69 | 0.026 |
5–9 cm | 73 | 38 | 183 | 54 | |
≥10 cm | 61 | 32 | 127 | 48 | |
Missing | 2 | 1 | |||
Malignancy grade FNCLCC | |||||
1 | 54 | 28 | NR | 81 | <0.001 |
2 | 76 | 39 | 80 | 55 | |
3 | 63 | 33 | 28 | 36 | |
Surgical margins | |||||
Wide | 97 | 50 | 254 | 66 | <0.001 |
Non-wide | 96 | 50 | 128 | 46 | |
Chemotherapy | |||||
No | 156 | 81 | 207 | 57 | 0.669 |
Yes | 37 | 19 | 180 | 51 | |
Radiotherapy | |||||
No | 132 | 68 | 216 | 58 | 0.190 |
Yes | 61 | 32 | 152 | 52 |